- Trials with a EudraCT protocol (565)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
565 result(s) found for: Injection site pain.
Displaying page 4 of 29.
EudraCT Number: 2008-000846-30 | Sponsor Protocol Number: 08I/DCsc04 | Start Date*: 2008-07-30 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: Open-label, randomised, controlled, parallel group study for the evaluation of safety and efficacy of Diclofenac HPBCD 75 mg ampoules s.c. in comparison with Diclofenac HPBCD 75 mg ampoules i.m. an... | |||||||||||||
Medical condition: Post-surgical pain in subjects undergoing one of the following minor orthopaedic interventions: arthroscopic meniscectomy, arthroscopic removal of bone fragments, surgical correction of hallux valgus; | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001510-33 | Sponsor Protocol Number: RR11/9781 | Start Date*: 2012-08-02 |
Sponsor Name:Leeds Teaching Hospitals R and D department | ||
Full Title: The Efficacy of Continuous Intra-articular Infusion of Local Anaesthetic Agent following Elective Primary Hip Arthroplasty | ||
Medical condition: Pain relief after surgery for patients who have undergone hip replacement due to osteoarthritis or other hip pathology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-021395-28 | Sponsor Protocol Number: B3D-MC-GHDN | Start Date*: 2012-04-03 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Effect of Teriparatide on Femoral Neck Fracture Healing | |||||||||||||
Medical condition: Low trauma femoral neck fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) LV (Completed) FI (Completed) NO (Completed) LT (Completed) EE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000967-10 | Sponsor Protocol Number: RC31/14/7441 | Start Date*: 2019-05-24 |
Sponsor Name:University Hospital Toulouse | ||
Full Title: Autologous transplantation of Adipose tissue derived mesenchymal Stroma/stem Cells (ASC) in patients with critical limb ischemia: a phase II study (ACellDream 2). | ||
Medical condition: Patients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CL... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000405-27 | Sponsor Protocol Number: 05JM128 | Start Date*: 2006-06-01 |
Sponsor Name:Greenpark Health Care Trust | ||
Full Title: Postoperative pain and mobility outcomes after primary hip and knee arthroplasty. A comparison of intravenous morphine with local wound infiltration. | ||
Medical condition: Osteoarthritis of the hip and knee joints | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001810-21 | Sponsor Protocol Number: 2022-001810-21 | Start Date*: 2022-08-23 | |||||||||||
Sponsor Name:Aarhus University Hospital, Department of Anaesthesiology | |||||||||||||
Full Title: Intraoperative clonidine for postoperative pain management in patients undergoing surgical treatment for endometriosis: a prospective, double-blind, randomized controlled trial | |||||||||||||
Medical condition: Endometriosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003413-18 | Sponsor Protocol Number: IM101 | Start Date*: 2014-05-13 | |||||||||||
Sponsor Name:King’s College London [...] | |||||||||||||
Full Title: Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept. | |||||||||||||
Medical condition: The target population for therapeutic intervention will be subjects who carry serum autoantibodies (antibodies to citrullinated protein antigens – ACPA; rheumatoid factor – RF) and who have joint p... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005544-33 | Sponsor Protocol Number: AUH-TFB-SR-ULMR | Start Date*: 2016-02-08 | ||||||||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | ||||||||||||||||||
Full Title: Shamrock – Ultrasound/MR image fusion guided lumbar plexus blocks | ||||||||||||||||||
Medical condition: Hip surgery anaesthesia and perioperative analgesia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001602-28 | Sponsor Protocol Number: HXV02C | Start Date*: 2013-07-05 |
Sponsor Name:Sanofi Pasteur MSD S.N.C. | ||
Full Title: An open-label, controlled, multi-centre study of the immunogenicity and safety of a challenge dose of HBVAXPRO® to explore the anamnestic immune response in healthy children vaccinated 10 years ago... | ||
Medical condition: HEALTHY CHILDREN | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004049-26 | Sponsor Protocol Number: MTX-071-P02 | Start Date*: 2017-11-23 | |||||||||||
Sponsor Name:Mestex | |||||||||||||
Full Title: Lopain (MTX-071 / resiniferatoxin) An open label, single dose phase Ib/IIa study to determine the safety and clinical effects of intra-articular injections of low doses of Lopain (MTX-071) in pa... | |||||||||||||
Medical condition: chronic osteoarthritic knee-joint pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004539-54 | Sponsor Protocol Number: TMP-0731-2018 | Start Date*: 2019-06-03 |
Sponsor Name:Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP | ||
Full Title: Capability of Tofacitinib or Etanercept to accelerate clinical relevant tapering of non-steroidal anti-inflammatory drugs and treat-to-target guided de-escalation of corticosteroids in patients wit... | ||
Medical condition: Patients with active Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001223-14 | Sponsor Protocol Number: VAJ00001 | Start Date*: 2020-11-13 | |||||||||||
Sponsor Name:Sanofi Pasteur SA | |||||||||||||
Full Title: Imovax® Rabies and VERORAB® Immunogenicity and Safety after One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Intradermal or Intramuscu... | |||||||||||||
Medical condition: Rabies disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005258-29 | Sponsor Protocol Number: B3D-MC-GHCY | Start Date*: 2006-04-12 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: The Effect of Teriparatide Compared with Risedronate on Back Pain in Postmenopausal Women with Osteoporotic Vertebral Fractures | ||
Medical condition: chronic back pain and osteoporotic vertebral fracture(s) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) ES (Completed) IT (Completed) BE (Completed) SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003232-31 | Sponsor Protocol Number: TDU11685-ACT12505 | Start Date*: 2011-11-03 | |||||||||||
Sponsor Name:sanofi-aventis recherche et développement | |||||||||||||
Full Title: A two part protocol to assess, using double blind placebo control, the safety, tolerability, and pharmacokinetics of ascending single doses of a new intra-articular administration formulation of SA... | |||||||||||||
Medical condition: KNEE OSTEOARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003185-33 | Sponsor Protocol Number: INRCA-02-2011 | Start Date*: 2011-10-13 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI IRCCS | |||||||||||||
Full Title: Prospective, controlled, randomized, blind study to evaluate the effects of intramuscular-paravertebral injections of an oxygen-ozone (O2-O3) mixture in patients with lumbar pain aged 65 or older | |||||||||||||
Medical condition: subjects aged 65 or older with lumbar pain and discopathy for at least 6 weeks | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010063-16 | Sponsor Protocol Number: F1J-EW-HMGQ | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy “The COMBO - DN (COmbination vs Monotherapy of pregaBalin and du... | |||||||||||||
Medical condition: diabetic peripheral neuropathic pain (DPNP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) SE (Completed) DE (Completed) GR (Completed) ES (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001720-21 | Sponsor Protocol Number: TAK-013/EC301 | Start Date*: 2004-12-24 | |||||||||||
Sponsor Name:Takeda Europe R&D Centre Ltd | |||||||||||||
Full Title: A Phase III, multi-center, randomized, double-blind comparator study to evaluate the efficacy and safety of 50 mg and 100 mg of TAK-013 tablets administered twice daily versus 3.75mg of Leuprolide ... | |||||||||||||
Medical condition: Endometriosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003467-60 | Sponsor Protocol Number: M13-741 | Start Date*: 2014-06-11 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis | |||||||||||||
Medical condition: Adult male and female patients with mild to moderate, symptomatic, radiographic and inflammatory osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) NL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001910-27 | Sponsor Protocol Number: V210-A03 | Start Date*: 2019-07-02 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc | |||||||||||||
Full Title: A Phase 3, Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Passage Extension 34 (PE34) Process Administered Concomitantl... | |||||||||||||
Medical condition: Prevention of varicella in individuals 12 months of age and older | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002641-42 | Sponsor Protocol Number: C4591001 | Start Date*: 2020-09-04 | |||||||||||
Sponsor Name:BioNTech SE | |||||||||||||
Full Title: A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COV... | |||||||||||||
Medical condition: Protection against COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
